HOLX
Hologic, Inc.NASDAQHealthcare$75.65+0.07%ClosedMarket Cap: $16.89B
As of 2026-04-06
Valuation
P/E (TTM)
31.05
PEG
—
P/B
3.24
P/S
4.09
EV/EBITDA
17.00
DCF Value
$104.90
FCF Yield
5.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.8%
Operating Margin
17.5%
Net Margin
13.2%
ROE
11.0%
ROA
10.9%
ROIC
7.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $1.05B | 56.0% | $237.0M | $179.1M | $0.79 | — |
| Q4 2025 | $1.05B | 60.9% | $237.0M | $187.3M | $0.83 | — |
| FY 2025 | $4.10B | 61.0% | $714.3M | $565.7M | $2.49 | — |
| Q3 2025 | $1.02B | 56.3% | $254.6M | $194.9M | $0.86 | — |
| Q2 2025 | $1.01B | 37.5% | $-7.0M | $-17.4M | $-0.08 | — |
| Q1 2025 | $1.02B | 56.8% | $229.8M | $201.0M | $0.87 | — |
| Q4 2024 | $988.0M | 56.4% | $230.0M | $178.6M | $0.76 | — |
| FY 2024 | $4.03B | 55.3% | $882.6M | $789.5M | $3.32 | — |
| Q3 2024 | $1.01B | 55.4% | $244.0M | $194.5M | $0.82 | — |
| Q2 2024 | $1.02B | 55.3% | $243.3M | $169.9M | $0.72 | — |
| Q1 2024 | $1.01B | 56.0% | $198.2M | $246.5M | $1.03 | — |
| Q4 2023 | $945.3M | 52.9% | $132.5M | $90.6M | $0.37 | — |